Abstract

Epigenetic mechanisms play key roles in initiation and progression of prostate cancer by changing gene expression. The Prostate Epigenetic Database (PEpiD: http://wukong.tongji.edu.cn/pepid) archives the three extensively characterized epigenetic mechanisms DNA methylation, histone modification, and microRNA implicated in prostate cancer of human, mouse, and rat. PEpiD uses a distinct color scheme to present the three types of epigenetic data and provides a user-friendly interface for flexible query. The retrieved information includes Refseq ID, gene symbol, gene alias, genomic loci of epigenetic changes, tissue source, experimental method, and supportive references. The change of histone modification (hyper or hypo) and the corresponding gene expression change (up or down) are also indicated. A graphic view of DNA methylation with exon-intron structure and predicted CpG islands is provided as well. Moreover, the prostate-related ENCODE tracks (DNA methylation, histone modifications, chromatin remodelers), and other key transcription factors with reported roles in prostate are displayed in the browser as well. The reversibility of epigenetic aberrations has made them potential markers for diagnosis and prognosis, and targets for treatment of cancers. This curated information will improve our understanding of epigenetic mechanisms of gene regulation in prostate cancer, and serve as an important resource for epigenetic research in prostate cancer.

Highlights

  • Prostate cancer (PC) is the most common form of noncutaneous cancer and a prominent cause of cancer death in men

  • Overview of the Database Prostate Epigenetic Database (PEpiD) stores three types of epigenetic data (DNA methylation, histone modification, microRNA) which previous studies indicated as involved in prostate cancer of human, mouse, and rat

  • PEpiD is a PC-specific epigenetic database consisting of DNA methylation, histone modification, and microRNA experimentally verified to be involved in PC

Read more

Summary

Introduction

Prostate cancer (PC) is the most common form of noncutaneous cancer and a prominent cause of cancer death in men. The major epigenetic factors include DNA methylation, histone modification, and non-coding RNAs, especially microRNA [1]. The pattern of histone modifications helped to maintain RASSF1A gene silencing with its promoter aberrant DNA methylation in prostate cancer [5]. None of the existing databases provide epigenetic changes involved in prostate cancer.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call